New Delhi: Drug firm AstraZeneca Pharma India reported a net profit of Rs 3.22 crore for the quarter ended March 31.
The company had posted a net loss of Rs 9.55 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a filing to BSE.
Revenue from operations of the company stood at Rs 150.72 crore for the quarter under consideration. It was Rs 116.88 crore in the year-ago period.
For the entire fiscal ended March, the company posted a net profit of Rs 25.91 crore. It was Rs 20.05 crore for the same period a year ago.
Revenue from operations of the company for 2017-18 stood at Rs 571.98 crore. It was Rs 548.65 crore in the previous fiscal.
Latest posts by Ruby Khatun (see all)
- JnJ faulty hip implants case: CIC directs RTI disclosure of records - September 10, 2018
- Max Bupa launches WeCare initiative to aid Kerala flood victims - September 10, 2018
- Opposing Online Pharmacies, 8.5 lakh chemists to call it a strike on September 28 - September 9, 2018